Tag: Varipulse Pro
J&J reports real-world Varipulse Pro data and 12-month Omnypulse outcomes at...
Johnson & Johnson (J&J) has announced new data from the VARIPURE and Omny-IRE studies presented at the 2026 Asia Pacific Heart Rhythm Society (APHRS)...
J&J launches “landmark” head-to-head pulsed field ablation trial in persistent AF
Johnson & Johnson (J&J) has announced the initiation of the PERSIGMA randomised controlled trial (RCT)—one of the first randomised studies evaluating competitive pulsed field...
J&J announces European launch of Varipulse Pro following CE-mark approval
Johnson & Johnson (J&J) has announced the launch of Varipulse Pro in Europe following CE-mark approval, advancing its pulsed field ablation (PFA) portfolio with...